CAS: 177947-96-5; Tert-Butyl 3-Formylazetidine-1-Carboxylate

该化合物是一种化学化合物,其特点是其有四人组成的环环结构,是一个有四人环状矿的化合物;一个气态组(CHO)的存在表明,它有一个甲状腺功能组(CHO),有助于其反应和有机合成中的潜在应用;异丁基酯的脂肪具有...

结构式图片

相似化合物

1638761-59-7 142253-55-2 142253-56-3

欧盟法规

ECHA物质C&L通报

上下游产品

3-hydroxymethyl-azetidine-1-carboxylic acid tert-butyl ester tert-butyl dicarbonatedi-tert-butyl dicarbonate 1-(t-butyloxycarbonyl)-azetidine-3-carboxylic acid carbon monoxide 3-((E)-2-ethoxycarbonylvinyl)azetidine-1-carboxylic acid tert-butyl ester 3-((E)-2-carboxyvinyl)azetidine-1-carboxylic acid tert-butyl ester 3-((E)-2-(methyl((1R)-1-(methyl((1R)-1-(methylcarbamoyl)-2-phenylethyl)carbamoyl)-2-(2-naphthyl)ethyl)carbamoyl)vinyl)azetidine-1-carboxylic acid tert-butyl ester 3-[4-(3-acetylaminophenyl)piperidin-1-ylmethyl]azetidine-1-carboxylic acid tert-butyl ester

合成工艺路线路线简述

  • 合成目标产物 3-Formyl-Azetidine-1-Carboxylic Acid Tert-Butyl Ester 主要起始原料 1-Boc-Azetidine-3-Yl-Methanol
  • 1248510-38-4 = 177947-96-5 + 852324-38-0
    反应条件:1.1 Reagents: Hydrogen Catalysts: Dicarbonylrhodium Acetylacetonate,2,2′,2′′,2′′′-[1,2-Phenylenebis[(1S,3S)-Tetrahydro-5,8-Dioxo-1H-[1,2,4]Diazaphos... Solvents: Toluene; 140 Psi,35 °C; 12 H,Cooled
    标题:Enantioselective Hydroformylation Of N-Vinyl Carboxamides,Allyl Carbamates,And Allyl Ethers Using Chiral Diazaphospholane Ligands
    作者:Mcdonald,Richard I.; Wong,Gene W.; Neupane,Ram P.; Stahl,Shannon S.; Landis,Clark R.
    参考文献:Journal Of The American Chemical Society 日期:2010 卷标:132(40) 页码:14027-14029
3-羟甲基氮杂环丁烷-1-羧酸叔丁酯置于草酰氯,三乙胺体系中,用 二氯甲烷,二甲基亚砜 用作溶剂,以65 %的收率获得3-甲酰基氮杂环丁烷-1-羧酸叔丁酯
参考文献:氟化脂肪二氮杂环丙烷:制备,表征和模型光标记研究
标题:氟化脂肪二氮杂环丙烷:制备,表征和模型光标记研究
摘要:合成并表征了以前未知的二氟甲基二氮杂环丙烷和以前被忽视的三氟甲基-脂肪族二氮杂环丙烷.模型光标记实验和生物学研究表明,这些化合物确实可以用作光亲和标记.
Doi:10.1021/acs.Joc.2C02262

海关参考信息

专利信息


专利号:US-10226449-B2
优先权日:2013-12-20
标 题:Heterocyclic modulators of lipid synthesis and combinations thereof
发明人:HEUER TIMOTHY SEAN; OSLOB JOHAN D; MCDOWELL ROBERT S; JOHNSON RUSSELL; YANG HANBIAO; EVANCHIK MARC; ZAHARIA CRISTIANA A; CAI HAIYING; HU LILY W; DUKE GREGORY; OHOL-GUPTA YAMINI; O'FARRELL MARIE
权利人:3 V BIOSCIENCES INC
摘要:Heterocyclic modulators of lipid synthesis are provided as well as pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising such compounds; and methods of treating conditions characterized by dysregulation of a fatty acid synthase pathway by the administration of such compounds and combinations of such compounds and other therapeutic agents.

专利号:US-9428502-B2
优先权日:2012-07-03
标题:Heterocyclic modulators of lipid synthesis
发明人:OSLOB JOHAN D; MCDOWELL ROBERT S; JOHNSON RUSSELL; YANG HANBIAO; EVANCHIK MARC; ZAHARIA CRISTIANA A; CAI HAIYING; HU LILY W; WAGMAN ALLAN S
权利人:3-V BIOSCIENCES INC
摘要:Heterocyclic modulators of lipid synthesis are provided as well as pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising such compounds; and methods of treating conditions characterized by disregulation of a fatty acid synthase pathway by the administration of such compounds.

专利号:US-9708336-B2
优先权日:2014-01-22
标题 :Metallo-beta-lactamase inhibitors
发明人:MANDAL MIHIR; TANG HAIFENG; XIAO LI; SU JING; LI GUOQING; YANG SHU-WEI; PAN WEIDONG; TANG HAIQUN; DEJESUS REYNALDA; HICKS JACQUELINE; LOMBARDO MATTHEW; CHU HONG; HAGMANN WILLIAM; PASTERNAK ALEX; GU XIN; JIANG JINLONG; DONG SHUZHI; DING FA-XIANG; LONDON CLARE; BISWAS DIPSHIKHA; YOUNG KATHERINE; HUNTER DAVID N; ZHAO ZHIQIANG; YANG DEXI
权利人:MERCK SHARP & DOHME
摘要:The present invention relates to compounds of formula (I) that are metallo-β-lactamase inhibitors, the synthesis of such compounds, and the use of such compounds for use with β-lactam antibiotics for overcoming resistance.

专利号:US-2013060019-A1
优先权日:2011-09-07
标 题 :Compounds for Use in Treating Neurodegenerative Disorders, Synthesis Thereof, and Intermediates Thereto
发明人:BRONK BRIAN SCOTT; AUSTIN WESLEY FRANCIS; CREASER STEFFEN PHILLIP; FULLER NATHAN OLIVER; HUBBS JED LEE; SHEN RUICHAO
权利人:BRONK BRIAN SCOTT; AUSTIN WESLEY FRANCIS; CREASER STEFFEN PHILLIP; FULLER NATHAN OLIVER; HUBBS JED LEE; SHEN RUICHAO; SATORI PHARMACEUTICALS INC
摘要:The present invention provides methods of making a compound of formula II: n n n n n n n n n n or a pharmaceutically acceptable salt thereof, wherein R 1 , R 2 , and L are as defined and described herein.

专利号:US-2018222892-A1
优先权日:2012-07-03
标 题 :Heterocyclic modulators of lipid synthesis

专利号:EP-3083583-B1
优先权日:2013-12-20
标 题:Heterocyclic modulators of lipid synthesis and combinations thereof
济南大宇化工有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.jinandayuchem.com
企业联系电话:0531-87153728👤
📞济南大宇化工有限公司 ⚠️参考联系方式
联系人:徐经理
电话:0531-87153728
手机:13805401165
传真:0531-87922099
邮箱:xufeng192@126.com xufeng192@jinandayuchem.com
通信地址: 济南市天桥区新材料交易产业园区西副楼
邮编: 250022
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:济南市天桥区新材料交易产业园区西副楼
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


参考文献:10.1055/s-0040-1720843
摘要:One-Pot Knoevenagel Condensation–Reduction Reaction of 2,4-Dihydroxy Quinolines and Pyridines. Synfacts. 2021 Aug 18;17(09):0974. doi: 10.1055/s-0040-1720843.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知